Daily Brief United States: Pfizer Inc, Golden Entertainment, Soybean Active Contract, Trane Technologies , Amazon, Apple , Crocs Inc, GRAIL, AXT Inc, Arrow Electronics and more

• Pfizer and Novo Nordisk engaged in a heated battle for control over biotech company Metcera, which is developing innovative weight loss drugs
• Novo Nordisk, once seen as a leader in the obesity drug market, has recently faced challenges and a decline in stock price due to competition from Eli Lilly and a weaker drug pipeline
• Investors are closely watching the outcome of the bidding war between Pfizer and Novo Nordisk, as the future of the weight loss drug market could be lucrative and competitive

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

• Golden Entertainment’s sale-leaseback with VICI involves 7 casinos, distributing 24.3m VICI shares to shareholders at 0.902/share.
• Chairman Blake Sartini’s privatization offer values RemainCo at $2.75/share, approximately 1x EBITDA, sparking activist opposition.
• Activists demand separate votes for transactions, citing inadequate RemainCo valuation and potential 33% upside to $39.5/share.

• Chinese purchases of US agricultural products are expected to increase gradually but may take time due to seasonality and price competitiveness
• US farmers may see more optimism in the 2026-2027 season as trade discussions with China improve and market participation increases
• The complex nature of US-China trade relations and the continued volatility in the agricultural markets make for a clouded outlook, but there is potential for growth and market shifts in the near future.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

• Trane Technologies delivered robust performance in the third quarter of 2025, exhibiting significant growth in key business segments despite challenges in certain markets.
• The company reported record quarterly bookings of $6 billion, reflecting a 13% year-over-year organic growth and expanding its adjusted operating margins by 170 basis points.
• Additionally, Trane Technologies achieved a 15% growth in adjusted earnings per share (EPS) and demonstrated robust free cash flow generation.

• Amazon.com reported robust financial results for the third quarter of 2025, highlighting both progress and challenges across its business segments.
• Total revenue reached $180.2 billion, marking a year-over-year increase of 12% when adjusting for foreign exchange impacts.
• Operating income was reported at $17.4 billion, however, this was impacted by two significant expenses: a $2.5 billion FTC settlement and $1.8 billion in estimated severance costs.

• Apple Inc. reported robust financial results for the fourth quarter of fiscal year 2025, showcasing an impressive performance with total revenue reaching $102.5 billion, an 8% increase from the same period last year, marking a record for the September quarter.
• The company’s services sector set an all-time revenue record with $28.8 billion, reflecting a substantial 15% growth, largely driven by strong demand across developed and emerging markets.
• Additionally, the company saw a record earning per share (EPS) of $1.85, marking another significant achievement.

• Crocs, Inc.’s third quarter of 2025 revealed a complex performance landscape driven by strategic decisions and market conditions.
• The company, known for both the Crocs and HEYDUDE brands, demonstrated efforts to realign its operations toward long-term growth despite short-term challenges.
• On the positive side, Crocs, Inc. showcased strong profitability and cash flow in the quarter, which facilitated share repurchases and debt reduction.

• With an in-line 3Q’FY25 revenue, the next major catalyst for GRAIL Inc. is the Galleri PMA submission to FDA, which is expected to occur in 1Q’FY26.  
• The #1 MCED screening test maker has guided to cash burn of <$290M for FY25 and the company’s cash position of $850M+ provides runway into 2030.
• Despite Galleri’s early stage, I view GRAIL Inc. as a very high quality company, which is a clear leader in MCED testing market in the United States.

• AXT is a key manufacturer of specialty compound semiconductor substrates (InP, GaAs, Ge), which are critical for high-performance applications where silicon is inadequate, such as 5G, data centers, and AI.
• The company is currently navigating a cyclical downturn, reflected in recent financial losses and negative cash flow. However, recent quarterly results suggest a potential recovery, driven by strong demand for Indium Phosphide (InP) substrates used in data center and AI applications.
• Significant geopolitical risk exists due to the company’s reliance on its manufacturing facilities in China and the associated export permit requirements, which have previously caused revenue delays.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Arrow Electronics Inc. has demonstrated a mixed bag of performance and outlook in the latest quarter, indicating areas of strength as well as challenges that the company faces.
• The company’s revenue for the third quarter of 2025 reached $7.7 billion, marking a significant increase of $890 million year-over-year.
• This was above the midpoint of the guidance range and reflects a 13% growth compared to the previous year.